Inhaled Budesonide Does Not Induce Cerebral Palsy, Other Neurological Impairments, in Extreme Preterm Infants, Study Finds
Administration of budesonide to extreme preterm newborns to prevent severe chronic pulmonary disease does not induce long-term neurodevelopmental impairments, such as cerebral palsy, cognitive delay, hearing impairment, or blindness, according to the results of a Phase 3 trial. The trial (NCT01035190) data were reported in an article…